BCITX
Price
$11.26
Change
-$0.00 (-0.00%)
Updated
Jun 17 closing price
Net Assets
2.25B
SRCMX
Price
$9.84
Change
+$0.01 (+0.10%)
Updated
Jun 17 closing price
Net Assets
683.47M
Interact to see
Advertisement

BCITX vs SRCMX

BCITX vs SRCMX Comparison Chart in %
View a ticker or compare two or three
VS
BCITX vs. SRCMX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCITX is a Hold and SRCMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BCITX has more cash in the bank: 2.25B vs. SRCMX (683M). SRCMX pays higher dividends than BCITX: SRCMX (3.48) vs BCITX (3.04). BCITX was incepted earlier than SRCMX: BCITX (43 years) vs SRCMX (37 years). SRCMX (0.85) is less costly to investors than BCITX (0.47). BCITX is a more actively managed with annual turnover of: 61.00 vs. SRCMX (52.20). SRCMX has a lower initial minimum investment than BCITX: SRCMX (1000) vs BCITX (2500). SRCMX (6.06) and BCITX (5.83) have marching annual gain over last year. BCITX return over 5 years is better than : 4.76 vs. SRCMX (-0.96).
BCITXSRCMXBCITX / SRCMX
Total Expense Ratio0.470.8555%
Annual Report Gross Expense Ratio0.470.8555%
Fund Existence43 years37 years-
Gain YTD1.0961.44076%
Front LoadN/A4%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B683M330%
Annual Yield % from dividends3.043.4887%
Returns for 1 year5.836.0696%
Returns for 3 years10.6511.1096%
Returns for 5 years4.76-0.96-495%
Returns for 10 years18.5215.91116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS12.010.27
+2.30%
Corvus Pharmaceuticals
CTVA77.370.50
+0.65%
Corteva
KTTA0.50-0.01
-1.51%
Pasithea Therapeutics Corp
FFIN32.57-0.82
-2.46%
First Financial Bankshares
JFIN3.92-0.15
-3.69%
Jiayin Group